Electronic symptom monitoring with patient-reported outcomes (PRO) meaningfully improves clinical outcomes for cancer treatment.

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults. The approval was supported by data from th ...

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful thrombectomy results in improved likelihood of excellent outcome (modified ...

The use of short-term hormone therapy for menopause is not associated with long-term cognitive impact after 10 years.

A study has found that in patients with ischemic heart disease receiving ventricular tachycardia ablation there is higher risk of mortality.

A scientific statement regarding pain and treatment considerations in patients with PAD has been published by the AHA.

Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within 1 year.

Infection-related hospitalization (IRH) is associated with incident heart failure, heart failure with preserved ejection fraction, and heart failure with reduced ejection fraction.

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

A presidential advisory has been published by the AHA regarding US government funding for the National Institutes of Health.

Researchers have found that, in the United States, adults with chronic disease, compared to those without, have worse cardiovascular health.

The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.